N-glycomic biomarkers of biological aging and longevity: A link with inflammaging

Adler, 1995, Impaired binding capacity of asialyl and agalactosyl IgG to Fcγ receptors, Clin. Exp. Rheumatol., 13, 315 Alavi, 2000, Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy, J. Rheumatol., 27, 1379 Alavi, 1995, Evaluation of β1,4-galactosyltransferase in rheumatoid arthritis and its role in the glycosylation network associated with this disease, Glycoconj. J., 12, 206, 10.1007/BF00731321 Alavi, 1995, β1,4-galactosyltransferase variations in rheumatoid arthritis, Adv. Exp. Med. Biol., 376, 185, 10.1007/978-1-4615-1885-3_19 Alavi, 1998, Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis, Ann. Med. Interne (Paris), 149, 251 Alavi, 2004, Serum galactosyltransferase isoform changes in rheumatoid arthritis, J. Rheumatol., 31, 1513 Albert, 2008, In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner, Proc. Natl. Acad. Sci. U.S.A., 105, 15005, 10.1073/pnas.0808248105 Anthony, 2011, Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway, Nature, 475, 110, 10.1038/nature10134 Anthony, 2008, Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc, Science, 320, 373, 10.1126/science.1154315 Anthony, 2008, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc. Natl. Acad. Sci. U.S.A., 105, 19571, 10.1073/pnas.0810163105 Arnold, 2006, Mannan binding lectin and its interaction with immunoglobulins in health and in disease, Immunol. Lett., 106, 103, 10.1016/j.imlet.2006.05.007 Arnold, 2008, Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation, Proteomics, 8, 3284, 10.1002/pmic.200800163 Arnold, 2007, The impact of glycosylation on the biological function and structure of human immunoglobulins, Annu. Rev. Immunol., 25, 21, 10.1146/annurev.immunol.25.022106.141702 Axford, 1994, Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis, Autoimmunity, 17, 157, 10.3109/08916939409014671 Axford, 2003, Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis, J. Rheumatol., 30, 2540 Axford, 1987, Reduced B-cell galactosyltransferase activity in rheumatoid arthritis, Lancet, 2, 1486, 10.1016/S0140-6736(87)92621-3 Axford, 1992, Changes in normal glycosylation mechanisms in autoimmune rheumatic disease, J. Clin. Invest., 89, 1021, 10.1172/JCI115643 Baerenwaldt, 2010, Mechanisms of action of intravenous immunoglobulins, Expert Rev. Clin. Immunol., 6, 425, 10.1586/eci.10.9 Barb, 2011, NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic, Nat. Chem. Biol., 7, 147, 10.1038/nchembio.511 Barker, 1999, Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia, Clin. Exp. Immunol., 117, 449, 10.1046/j.1365-2249.1999.01001.x Biagi, 2011, The aging gut microbiota: new perspectives, Ageing Res. Rev., 10, 428, 10.1016/j.arr.2011.03.004 Biagi, 2010, Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians, PLoS ONE, 5, e10667, 10.1371/journal.pone.0010667 Bodman, 1994, IgG glycosylation in autoimmune-prone strains of mice, Clin. Exp. Immunol., 95, 103, 10.1111/j.1365-2249.1994.tb06022.x Bodman, 1992, Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro, Clin. Exp. Immunol., 88, 420, 10.1111/j.1365-2249.1992.tb06465.x Bonafe, 2012, Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people, Bioessays, 34, 40, 10.1002/bies.201100104 Bones, 2011, Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms, J. Proteome Res., 10, 1246, 10.1021/pr101036b Callewaert, 2001, Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment, Glycobiology, 11, 275, 10.1093/glycob/11.4.275 Cevenini, 2010, Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies, Curr. Pharm. Des., 16, 802, 10.2174/138161210790883660 Cevenini, 2010, Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches, Curr. Pharm. Des., 16, 609, 10.2174/138161210790883840 Childs, 2009, Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray, Nat. Biotechnol., 27, 797, 10.1038/nbt0909-797 Chiricolo, 2006, Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948, Glycobiology, 16, 146, 10.1093/glycob/cwj045 Cingle, 1996, Age-related changes of glycosidases in human retinal pigment epithelium, Curr. Eye Res., 15, 433, 10.3109/02713689608995834 Croce, 2007, Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis, J. Clin. Lab. Anal., 21, 303, 10.1002/jcla.20191 Dahms, 1989, Mannose 6-phosphate receptors and lysosomal enzyme targeting, J. Biol. Chem., 264, 12115, 10.1016/S0021-9258(18)63825-6 Dall’Olio, 2012, Glycosylation in cancer, Spec.Periodical Rep. Carbohydr.Chem., 37, 21, 10.1039/9781849732765-00021 Dall’Olio, 2012, Mechanisms of cancer-associated glycosylation changes, Front.Biosci., 17, 670, 10.2741/3951 Das, 2004, Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis, Clin. Rheumatol., 23, 218, 10.1007/s10067-003-0860-9 Davies, 2001, Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII, Biotechnol. Bioeng., 74, 288, 10.1002/bit.1119 Delves, 1990, Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients, Arthritis Rheum., 33, 1655, 10.1002/art.1780331108 Dong, 1999, Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells, J. Immunol., 163, 5427, 10.4049/jimmunol.163.10.5427 Dube, 1990, Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein, Gut, 31, 431, 10.1136/gut.31.4.431 Endo, 1993, Structural changes in the N-linked sugar chains of serum immunoglobulin G of HTLV-I transgenic mice, Biochem. Biophys. Res. Commun., 192, 1004, 10.1006/bbrc.1993.1516 Endo, 1989, Structural study of the carbohydrate moieties of two human immunoglobulin subclasses (IgG2 and IgG4), Glycoconj. J., 6, 57, 10.1007/BF01047890 Ercan, 2010, Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis, Arthritis Rheum., 62, 2239, 10.1002/art.27533 Ezekowitz, 1995, Agalactosyl IgG and mannose-binding proteins: biochemical nicety or pathophysiological paradigm?, Nat. Med., 1, 207, 10.1038/nm0395-207 Ferrara, 2011, Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose, Proc. Natl. Acad. Sci. U.S.A., 108, 12669, 10.1073/pnas.1108455108 Field, 1994, Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis, Biochem. J., 299, 261, 10.1042/bj2990261 Filley, 1989, A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum, Clin. Exp. Immunol., 76, 343 Flogel, 1998, Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis, Clin. Chem. Lab. Med., 36, 99, 10.1515/CCLM.1998.018 Franceschi, 2007, Inflammaging as a major characteristic of old people: can it be prevented or cured?, Nutr. Rev., 65, S173, 10.1301/nr.2007.dec.S173-S176 Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann. N. Y. Acad. Sci., 908, 244, 10.1111/j.1749-6632.2000.tb06651.x Franceschi, 2007, Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans, Mech. Ageing Dev., 128, 92, 10.1016/j.mad.2006.11.016 Furukawa, 1990, Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis, Int. Immunol., 2, 105, 10.1093/intimm/2.1.105 Garred, 2000, Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study, J. Rheumatol., 27, 26 Ghosh, 2003, Mannose 6-phosphate receptors: new twists in the tale, Nat. Rev. Mol. Cell Biol., 4, 202, 10.1038/nrm1050 Gornik, 1999, Fucosylation of IgG heavy chains is increased in rheumatoid arthritis, Clin. Biochem., 32, 605, 10.1016/S0009-9120(99)00060-0 Gornik, 2009, Stability of N-glycan profiles in human plasma, Glycobiology, 19, 1547, 10.1093/glycob/cwp134 Griffiths, 1989, The effects of oxygen free radicals on the carbohydrate moiety of IgG, FEBS Lett., 245, 95, 10.1016/0014-5793(89)80199-1 Groenink, 1996, On the interaction between agalactosyl IgG and Fc gamma receptors, Eur. J. Immunol., 26, 1404, 10.1002/eji.1830260634 Gui, 2010, Altered serum N-glycomics in chronic hepatitis B patients, Liver Int., 30, 259, 10.1111/j.1478-3231.2009.02170.x Guo, 2001, Galactosylation of N-linked oligosaccharides by human β-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells, Glycobiology, 11, 813, 10.1093/glycob/11.10.813 Ha, 2011, Isolation and characterization of IgG1 with asymmetrical Fc glycosylation, Glycobiology, 21, 1087, 10.1093/glycob/cwr047 Hart, 2010, Glycomics hits the big time, Cell, 143, 672, 10.1016/j.cell.2010.11.008 Hebert, 2005, The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags, Trends Cell Biol., 15, 364, 10.1016/j.tcb.2005.05.007 Herscovics, 2001, Structure and function of Class I alpha 1,2-mannosidases involved in glycoprotein synthesis and endoplasmic reticulum quality control, Biochimie, 83, 757, 10.1016/S0300-9084(01)01319-0 Hitsumoto, 1992, Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis, Autoimmunity, 11, 247, 10.3109/08916939209035162 Holland, 2002, Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis, Clin. Exp. Immunol., 129, 183, 10.1046/j.1365-2249.2002.01864.x Holland, 2006, Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis, Biochim. Biophys. Acta, 1760, 669, 10.1016/j.bbagen.2005.11.021 Hummasti, 2010, Endoplasmic reticulum stress and inflammation in obesity and diabetes, Circ. Res., 107, 579, 10.1161/CIRCRESAHA.110.225698 Ihara, 1993, cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III), J. Biochem. (Tokyo), 113, 692, 10.1093/oxfordjournals.jbchem.a124105 Iida, 2009, Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood, BMC Cancer, 9, 58, 10.1186/1471-2407-9-58 Iida, 2006, Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcγRIIIa, Clin. Cancer Res., 12, 2879, 10.1158/1078-0432.CCR-05-2619 Imafuku, 2003, Reactivity of agalactosyl IgG with rheumatoid factor, Clin. Chim. Acta, 334, 217, 10.1016/S0009-8981(03)00245-6 Isenberg, 1995, Abnormalities in the glycosylation of IgG and its clinical utility, Adv. Exp. Med. Biol., 376, 179, 10.1007/978-1-4615-1885-3_18 Jeddi, 1999, The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G, Immunology, 98, 475, 10.1046/j.1365-2567.1999.00896.x Jeddi, 1996, Agalactosyl IgG and β-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse, Immunology, 87, 654, 10.1046/j.1365-2567.1996.474593.x Jeddi, 1994, Reduced galactosyltransferase mRNA levels are associated with the agalactosyl IgG found in arthritis-prone MRL-lpr/lpr strain mice, Immunology, 83, 484 Jefferis, 1990, A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins, Biochem. J., 268, 529, 10.1042/bj2680529 Kaneko, 2006, Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, 313, 670, 10.1126/science.1129594 Kanoh, 2004, Changes in serum IgG oligosaccharide chains with prostate cancer progression, Anticancer Res., 24, 3135 Kanoh, 2004, Analysis of the oligosaccharide chain of human serum immunoglobulin G in patients with localized or metastatic cancer, Oncology, 66, 365, 10.1159/000079484 Kanoh, 2006, Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression, Anticancer Res., 26, 4293 Kanoh, 2008, Changes to N-linked oligosaccharide chains of human serum immunoglobulin G and matrix metalloproteinase-2 with cancer progression, Anticancer Res., 28, 715 Keusch, 1998, B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis, Glycoconj. J., 15, 1093, 10.1023/A:1006957711557 Keusch, 1998, The effect on IgG glycosylation of altering β1,4-galactosyltransferase-1 activity in B cells, Glycobiology, 8, 1215, 10.1093/glycob/8.12.1215 Kibe, 1996, Glycosylation and placental transport of Immunoglobulin G, J. Clin. Biochem. Nutr., 21, 57, 10.3164/jcbn.21.57 Kido, 1999, Normal levels of serum glycoproteins maintained in β-1,4-galactosyltransferase I-knockout mice, FEBS Lett., 464, 75, 10.1016/S0014-5793(99)01681-6 Kiss, 1997, Cell biology of polysialic acid, Curr. Opin. Neurobiol., 7, 640, 10.1016/S0959-4388(97)80083-9 Kjeldsen-Kragh, 1996, Changes in glycosylation of IgG during fasting in patients with rheumatoid arthritis, Br. J. Rheumatol., 35, 117, 10.1093/rheumatology/35.2.117 Knezevic, 2010, Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans, Glycobiology, 20, 959, 10.1093/glycob/cwq051 Knezevic, 2009, Variability, heritability and environmental determinants of human plasma N-glycome, J. Proteome Res., 8, 694, 10.1021/pr800737u Kobata, 2003, Glycobiology in the field of aging research-introduction to glycogerontology, Biochimie, 85, 13, 10.1016/S0300-9084(03)00003-8 Kono, 2008, How dying cells alert the immune system to danger, Nat. Rev. Immunol., 8, 279, 10.1038/nri2215 Kornfeld, 1985, Assembly of asparagine-linked oligosaccharides, Annu. Rev. Biochem., 54, 631, 10.1146/annurev.bi.54.070185.003215 Kotani, 2001, Knockout of mouse β1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins, Biochem. J., 357, 827, 10.1042/0264-6021:3570827 Krapp, 2003, Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity, J. Mol. Biol., 325, 979, 10.1016/S0022-2836(02)01250-0 Kumpel, 1995, The biological activity of human monoclonal IgG anti-D is reduced by β-galactosidase treatment, Hum. Antibodies Hybridomas, 6, 82, 10.3233/HAB-1995-6301 Kuroda, 2001, Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis, Pathol. Int., 51, 909, 10.1046/j.1440-1827.2001.01306.x Kuroda, 2001, Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background, FEBS Lett., 507, 210, 10.1016/S0014-5793(01)02974-X Laroy, 2006, Glycome mapping on DNA sequencing equipment, Nat. Protoc., 1, 397, 10.1038/nprot.2006.60 Lastra, 1998, Changes in the galactose content of IgG during humoral immune responses, Autoimmunity, 28, 25, 10.3109/08916939808993842 Lau, 2007, Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation, Cell, 129, 123, 10.1016/j.cell.2007.01.049 Lauc, 2010, Genomics meets glycomics—the first GWAS study of human N-glycome identifies HNF1α as a master regulator of plasma protein fucosylation, PLoS Genet., 6, e1001256, 10.1371/journal.pgen.1001256 Lauc, 2009, Genome-wide association study identifies FUT8 and ESR2 as co-regulators of a bi-antennary N-linked glycan A2 (GlcNAc2Man3GlcNAc2) in human plasma proteins, Nat. Precedings, 10.1038/npre.2009.2864.1 Leader, 1996, Agalactosyl IgG in aggregates from the rheumatoid joint, Br. J. Rheumatol., 35, 335, 10.1093/rheumatology/35.4.335 Lee, 2008, Protein sialylation by sialyltransferase involves radiation resistance, Mol. Cancer Res., 6, 1316, 10.1158/1541-7786.MCR-07-2209 Leirisalo-Repo, 1999, Agalactosyl IgG is elevated in patients with active spondyloarthropathy, Rheumatol. Int., 18, 171, 10.1007/s002960050080 Liu, 2009, Reduced expression of α-1,2-mannosidase I extends lifespan in Drosophila melanogaster and Caenorhabditis elegans, Aging Cell, 8, 370, 10.1111/j.1474-9726.2009.00471.x Maeno, 2004, Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjogren's syndrome, and healthy children, J. Rheumatol., 31, 1211 Malhotra, 1995, Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein, Nat. Med., 1, 237, 10.1038/nm0395-237 Marcos, 2008, Helicobacter pylori induces β3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x, J. Clin. Invest., 118, 2325 Martin, 2001, Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis, J. Rheumatol., 28, 1531 Matsumoto, 2000, Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation, J. Biochem. (Tokyo), 128, 621, 10.1093/oxfordjournals.jbchem.a022794 Mattu, 1998, The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions, J. Biol. Chem., 273, 2260, 10.1074/jbc.273.4.2260 Mehta, 2008, Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis, J. Virol., 82, 1259, 10.1128/JVI.01600-07 Mimura, 2007, Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry, J. Immunol. Methods, 326, 116, 10.1016/j.jim.2007.07.014 Mimura, 2005, Rheumatoid factor isotypes in localized scleroderma, Clin. Exp. Dermatol., 30, 405, 10.1111/j.1365-2230.2005.01776.x Mimura, 2004, Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis, Br. J. Dermatol., 151, 803, 10.1111/j.1365-2133.2004.06195.x Mimura, 2005, Serum levels of anti-agalactosyl IgG antibodies in mixed connective tissue disease, Br. J. Dermatol., 152, 806, 10.1111/j.1365-2133.2005.06478.x Molinari, 2007, N-glycan structure dictates extension of protein folding or onset of disposal, Nat. Chem. Biol., 3, 313, 10.1038/nchembio880 Nakagawa, 2007, Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 853, 133, 10.1016/j.jchromb.2007.03.003 Nakajima, 2011, Functional analysis of agalactosyl IgG in inflammatory bowel disease patients, Inflamm. Bowel Dis., 17, 927, 10.1002/ibd.21459 Nakao, 1991, Hypogalactosylation of immunoglobulin G sugar chains and elevated serum interleukin 6 in Castleman's disease, Clin. Chim. Acta, 197, 221, 10.1016/0009-8981(91)90142-Y Narasimhan, 1982, Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide β4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in β1-4 linkage to the β-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides, J. Biol. Chem., 257, 10235, 10.1016/S0021-9258(18)34010-9 Nimmerjahn, 2007, Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity, Proc. Natl. Acad. Sci. U.S.A., 104, 8433, 10.1073/pnas.0702936104 Nimmerjahn, 2006, Fcγ receptors: old friends and new family members, Immunity, 24, 19, 10.1016/j.immuni.2005.11.010 Nimmerjahn, 2007, The antiinflammatory activity of IgG: the intravenous IgG paradox, J. Exp. Med., 204, 11, 10.1084/jem.20061788 Nimmerjahn, 2008, Anti-inflammatory actions of intravenous immunoglobulin, Annu. Rev. Immunol., 26, 513, 10.1146/annurev.immunol.26.021607.090232 Nimmerjahn, 2008, Fcγ receptors as regulators of immune responses, Nat. Rev. Immunol., 8, 34, 10.1038/nri2206 Nishijima, 2001, Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis, J. Rheumatol., 28, 1847 Niwa, 2005, IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides, J. Immunol. Methods, 306, 151, 10.1016/j.jim.2005.08.009 Ohtsubo, 2006, Glycosylation in cellular mechanisms of health and disease, Cell, 126, 855, 10.1016/j.cell.2006.08.019 Ohyama, 2002, Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides, Proc. Natl. Acad. Sci. U.S.A., 99, 13789, 10.1073/pnas.212456599 Omtvedt, 2006, Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans, Arthritis Rheum., 54, 3433, 10.1002/art.22171 Pang, 2011, Human sperm binding is mediated by the sialyl-Lewis x oligosaccharide on the zona pellucida, Science, 333, 1761, 10.1126/science.1207438 Parekh, 1989, A comparative analysis of disease-associated changes in the galactosylation of serum IgG, J. Autoimmun., 2, 101, 10.1016/0896-8411(89)90148-0 Parekh, 1988, Age-related galactosylation of the N-linked oligosaccharides of human serum IgG, J. Exp. Med., 167, 1731, 10.1084/jem.167.5.1731 Parekh, 1988, Rheumatoid arthritis as a glycosylation disorder, Br. J. Rheumatol., 27, 162, 10.1093/rheumatology/XXVII.suppl_2.162 Parekh, 1985, Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG, Nature, 316, 452, 10.1038/316452a0 Parekh, 1988, Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity, Lancet, 1, 966, 10.1016/S0140-6736(88)91781-3 Pasek, 2006, Galactosylation of IgG from rheumatoid arthritis (RA) patients—changes during therapy, Glycoconj. J., 23, 463, 10.1007/s10719-006-5409-0 Peipp, 2008, Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells, Blood, 112, 2390, 10.1182/blood-2008-03-144600 Pekelharing, 1988, Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women, Ann. Rheum. Dis., 47, 91, 10.1136/ard.47.2.91 Perdivara, 2011, Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes, J. Proteome Res., 10, 2969, 10.1021/pr200397h Phillips, 1990, ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex, Science, 250, 1130, 10.1126/science.1701274 Pierce, 2010, Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients, Glycobiology, 20, 1283, 10.1093/glycob/cwq090 Pilkington, 1996, Raised levels of agalactosyl IgG in childhood tuberculosis, Trans. R. Soc. Trop. Med. Hyg., 90, 167, 10.1016/S0035-9203(96)90124-8 Pilkington, 1995, Neonatal myasthenia gravis and the role of agalactosyl IgG, Autoimmunity, 21, 131, 10.3109/08916939508993361 Pilkington, 1996, Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus, Rheumatol. Int., 16, 89, 10.1007/BF01409979 Pilkington, 1995, Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis, Autoimmunity, 22, 107, 10.3109/08916939508995306 Pinho, 2011, Modulation of E-cadherin function and dysfunction by N-glycosylation, Cell Mol. Life Sci., 68, 1011, 10.1007/s00018-010-0595-0 Pucic, 2011, High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations, Mol. Cell. Proteomics, 10, M111, 10.1074/mcp.M111.010090 Pucic, 2010, Common aberrations from the normal human plasma N-glycan profile, Glycobiology, 20, 970, 10.1093/glycob/cwq052 Rademacher, 1991, Network theory of glycosylation—etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity, Semin. Cell Biol., 2, 327 Rademacher, 1988, The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis, Springer Semin. Immunopathol., 10, 231, 10.1007/BF01857227 Rademacher, 1994, Agalactosyl glycoforms of IgG autoantibodies are pathogenic, Proc. Natl. Acad. Sci. U.S.A., 91, 6123, 10.1073/pnas.91.13.6123 Raju, 2008, Terminal sugars of Fc glycans influence antibody effector functions of IgGs, Curr. Opin. Immunol., 20, 471, 10.1016/j.coi.2008.06.007 Rook, 1991, The role of oil and agalactosyl IgG in the induction of arthritis in rodent models, Eur. J. Immunol., 21, 1027, 10.1002/eji.1830210425 Rook, 1994, A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy, Immunology, 81, 149 Rook, 1991, Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy, J. Autoimmun., 4, 779, 10.1016/0896-8411(91)90173-A Royle, 2008, HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software, Anal. Biochem., 376, 1, 10.1016/j.ab.2007.12.012 Rudd, 2001, Glycosylation and the immune system, Science, 291, 2370, 10.1126/science.291.5512.2370 Ruhaak, 2010, Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF, J. Proteome Res., 9, 6655, 10.1021/pr100802f Ruhaak, 2008, Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins, Anal. Chem., 80, 6119, 10.1021/ac800630x Ruhaak, 2011, Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health, J. Proteome Res., 10, 1667, 10.1021/pr1009959 Ruhaak, 2010, Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity, PLoS ONE, 5, e12566, 10.1371/journal.pone.0012566 Saldova, 2007, Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG, Glycobiology, 17, 1344, 10.1093/glycob/cwm100 Sato, 1998, Comparison of lectin-binding patterns between young adults and older rat glycoproteins in the brain, Glycoconj. J., 15, 1133, 10.1023/A:1006911821339 Satoh, 2006, Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies, Expert Opin. Biol. Ther., 6, 1161, 10.1517/14712598.6.11.1161 Scallon, 2007, Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality, Mol. Immunol., 44, 1524, 10.1016/j.molimm.2006.09.005 Scherer, 2010, Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid, Arthritis Rheum., 62, 1620, 10.1002/art.27414 Schumacher, 2008, Delayed and accelerated aging share common longevity assurance mechanisms, PLoS Genet., 4, e1000161, 10.1371/journal.pgen.1000161 Selman, 2011, IgG Fc N-glycosylation changes in Lambert–Eaton myasthenic syndrome and myasthenia gravis, J. Proteome Res., 10, 143, 10.1021/pr1004373 Shaikh, 2008, Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms, Exp. Cell Res., 314, 2941, 10.1016/j.yexcr.2008.07.021 Shibata-Koyama, 2009, Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils, Exp. Hematol., 37, 309, 10.1016/j.exphem.2008.11.006 Shibuya, 1987, The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(α 2-6)Gal/GalNAc sequence, J. Biol. Chem., 262, 1596, 10.1016/S0021-9258(19)75677-4 Shields, 2002, Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcγ RIII and antibody-dependent cellular toxicity, J. Biol. Chem., 277, 26733, 10.1074/jbc.M202069200 Shikata, 1998, Structural changes in the oligosaccharide moiety of human IgG with aging, Glycoconj. J., 15, 683, 10.1023/A:1006936431276 Shinkawa, 2003, The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity, J. Biol. Chem., 278, 3466, 10.1074/jbc.M210665200 Shinzaki, 2008, IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease, Am. J. Gastroenterol., 103, 1173, 10.1111/j.1572-0241.2007.01699.x Soltys, 1994, The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content, Scand. J. Immunol., 40, 135, 10.1111/j.1365-3083.1994.tb03442.x Stanworth, 1998, Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis, Br. J. Rheumatol., 37, 186, 10.1093/rheumatology/37.2.186 Sumar, 1991, Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor, Ann. Rheum. Dis., 50, 607, 10.1136/ard.50.9.607 Swindall, 2011, Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells, J. Biol. Chem., 286, 22982, 10.1074/jbc.M110.211375 Tchkonia, 2010, Fat tissue, aging, and cellular senescence, Aging Cell, 9, 667, 10.1111/j.1474-9726.2010.00608.x Tei, 2002, Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats, Cancer Res., 62, 6289 Terai, 2006, Degalactosylated and/or denatured IgA, but not native IgA in any form, bind to mannose-binding lectin, J. Immunol., 177, 1737, 10.4049/jimmunol.177.3.1737 Thompson, 1992, Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG, Clin. Exp. Immunol., 89, 434, 10.1111/j.1365-2249.1992.tb06976.x Tomaiuolo, 2012, Activity of mannose-binding lectin (MBL) in centenarians, Aging Cell, 10.1111/j.1474-9726.2012.00793.x Troelsen, 2007, Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis, Arthritis Rheum., 56, 21, 10.1002/art.22302 Tsuchiya, 1998, Use of lectin for detection of agalactosyl IgG, Methods Mol. Med., 9, 195 Tsuchiya, 1993, Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin, J. Immunol., 151, 1137, 10.4049/jimmunol.151.2.1137 Umana, 1999, Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity, Nat. Biotechnol., 17, 176, 10.1038/6179 Van Beneden, 2009, Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis, Ann. Rheum. Dis., 68, 1360, 10.1136/ard.2008.089292 van de Geijn, 2009, Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study, Arthritis Res. Ther., 11, R193, 10.1186/ar2892 Van Zeben, 1994, Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study, Br. J. Rheumatol., 33, 36, 10.1093/rheumatology/33.1.36 Vanhooren, 2007, N-glycomic changes in serum proteins during human aging, Rejuvenation Res., 10, 521, 10.1089/rej.2007.0556 Vanhooren, 2011, Alteration in N-glycomics during mouse aging: a role for FUT8, Aging Cell, 10, 1056, 10.1111/j.1474-9726.2011.00749.x Vanhooren, 2010, N-glycan profile shift during human ageing, Exp. Gerontol., 45, 738, 10.1016/j.exger.2010.08.009 Vanhooren, 2008, N-Glycan profiling in the study of human aging, Biogerontology, 9, 351, 10.1007/s10522-008-9140-z Vanhooren, 2009, N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing, Mech. Ageing Dev., 130, 92, 10.1016/j.mad.2008.11.008 Varki, 1993, Biological roles of oligosaccharides: all of the theories are correct, Glycobiology, 3, 97, 10.1093/glycob/3.2.97 Vescovini, 2007, Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects, J. Immunol., 179, 4283, 10.4049/jimmunol.179.6.4283 Wang, 2011, Fc-glycosylation of IgG1 is modulated by B-cell stimuli, Mol. Cell. Proteomics, 10, M110, 10.1074/mcp.M110.004655 Weindruch, 1988, Influences of aging and dietary restriction on serum thymosin α 1 levels in mice, J. Gerontol., 43, B40, 10.1093/geronj/43.2.B40 Williams, 1995, Short communication: selective placental transport of maternal IgG to the fetus, Placenta, 16, 749, 10.1016/0143-4004(95)90018-7 Wong, 1993, Analysis of carbohydrate-protein interactions with synthetic N-linked neoglycoconjugate probes, Biochem. J., 296, 817, 10.1042/bj2960817 Wormald, 1997, Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides, Biochemistry, 36, 1370, 10.1021/bi9621472 Wuhrer, 2009, Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry, Mass Spectrom. Rev., 28, 192, 10.1002/mas.20195 Yabe, 2010, Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans, FEBS J., 277, 4010, 10.1111/j.1742-4658.2010.07792.x Yagev, 1993, Adjuvant arthritis is associated with changes in the glycosylation of serum IgG1 and IgG2b, Clin. Exp. Immunol., 94, 452, 10.1111/j.1365-2249.1993.tb08217.x Yamada, 1997, Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum, Glycoconj. J., 14, 401, 10.1023/A:1018582930906 Yamada, 2006, Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors, Nature, 444, 378, 10.1038/nature05264 Yamaguchi, 2006, Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy, Biochim. Biophys. Acta, 1760, 693, 10.1016/j.bbagen.2005.10.002 Yanagidani, 1997, Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-β-d-glucosaminide:α1-6 fucosyltransferase (α1-6 FucT) from human gastric cancer MKN45 cells, J. Biochem. (Tokyo), 121, 626, 10.1093/oxfordjournals.jbchem.a021631 Youings, 1996, Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients, Biochem. J., 314, 621, 10.1042/bj3140621 Young, 1991, Agalactosyl IgG: an aid to differential diagnosis in early synovitis, Arthritis Rheum., 34, 1425, 10.1002/art.1780341113 Zhu, 2006, Beta-mannosidosis mice: a model for the human lysosomal storage disease, Hum. Mol. Genet., 15, 493, 10.1093/hmg/ddi465 Zou, 2000, Genome-wide study of aging and oxidative stress response in Drosophila melanogaster, Proc. Natl. Acad. Sci. U.S.A., 97, 13726, 10.1073/pnas.260496697